# US 2019/0167742 A1 · Therapy for promoting cell growth > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 2019/0167742 A1 - Document ID: US20190167742A1 - Status: Published application - Kind: A1 - Application number: 16/242,654 - Filed: 2019-01-08 - Published: 2019-06-06 - Earliest claimed: 2009-03-27 - Assignees: Moleac Pte. Ltd. - Applicants: Moleac Pte. Ltd. - Inventors: Michel Maurice Jacques Lazdunski; Catherine Louise Heurteaux; David Picard - Web page: https://patentgrep.com/patent/US20190167742A1 ## CPC - A61K 36/232: Angelica - A61K 35/62: Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia - A61K 36/236: Ligusticum (licorice-root) - A61K 36/286: Carthamus (distaff thistle) - A61K 36/481: Astragalus (milkvetch) - A61K 36/537: Salvia (sage) - A61K 36/65: Paeoniaceae (Peony family), e.g. Chinese peony - A61K 36/69: Polygalaceae (Milkwort family) - A61K 36/736: Prunus, e.g. plum, cherry, peach, apricot or almond - A61K 36/882: Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus - A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca - A61P 9/00: Drugs for disorders of the cardiovascular system - A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis - A61P 21/00: Drugs for disorders of the muscular or neuromuscular system - A61P 21/02: Muscle relaxants, e.g. for tetanus or cramps - A61P 25/00: Drugs for disorders of the nervous system - A61P 25/02: for peripheral neuropathies - A61P 25/06: Antimigraine agents - A61P 25/08: Antiepileptics; Anticonvulsants - A61P 25/14: for treating abnormal movements, e.g. chorea, dyskinesia - A61P 25/24: Antidepressants - A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia - A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 - A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00) - A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D) - A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS ## Abstract There is disclosed the use of a composition for promoting neuronal growth of neurons in tissues of the central or peripheral nervous system. There is also disclosed a method for inducing proliferation or differentiation of neuronal cells. ## Claims ### Claim at position 1 1-73. (canceled) ### Claim 74 A composition consisting of the following four herbal components: i) Radix Polygalae; ii) Radix Astragali; iii) Rhizoma Chuanxiong; and iv) Radix Angelicae sinensis, wherein each herbal component is present in the composition as an unprocessed or crushed herb or as a purified extract. ### Claim 75 (depends on 74) The composition according to claim 74, wherein each herbal component is present in the composition as a purified extract. ### Claim 76 (depends on 74) The composition according to claim 74, wherein Radix Polygalae, Rhizoma Chuanxiong, Radix Angelicae sinensis, and Radix Astragali are present in the composition in a ratio of about 1:1:1:5 by weight, respectively. ### Claim 77 (depends on 75) The composition according to claim 75, wherein Radix Polygalae, Rhizoma Chuanxiong, Radix Angelicae sinensis, and Radix Astragali are present in the composition in a ratio of about 1:1:1:5 by weight, respectively. ### Claim 78 (depends on 74) The composition according to claim 74, wherein said composition is a pharmaceutical composition further comprising a pharmaceutically acceptable additive, carrier or diluent. ### Claim 79 (depends on 75) The composition according to claim 75, wherein said composition is a pharmaceutical composition further comprising a pharmaceutically acceptable additive, carrier or diluent. ### Claim 80 (depends on 76) The composition according to claim 76, wherein said composition is a pharmaceutical composition further comprising a pharmaceutically acceptable additive, carrier or diluent. ### Claim 81 (depends on 77) The composition according to claim 77, wherein said composition is a pharmaceutical composition further comprising a pharmaceutically acceptable additive, carrier or diluent. ### Claim 82 (depends on 78) The composition according to claim 78, formulated for oral delivery. ### Claim 83 (depends on 79) The composition according to claim 79, formulated for oral delivery. ### Claim 84 (depends on 80) The composition according to claim 80, formulated for oral delivery. ### Claim 85 (depends on 81) The composition according to claim 81, formulated for oral delivery. ### Claim 86 (depends on 78) The composition according to claim 78, formulated as one or more tablets or capsules. ### Claim 87 (depends on 79) The composition according to claim 79, formulated as one or more tablets or capsules. ### Claim 88 (depends on 80) The composition according to claim 80, formulated as one or more tablets or capsules. ### Claim 89 (depends on 81) The composition according to claim 81, formulated as one or more tablets or capsules. ### Claim 90 (depends on 78) The composition according to claim 78, administered to a subject to diminish the effects of a stroke and/or a neurodegenerative disorder, wherein said composition is administered in combination with one or more supplemental agents. ### Claim 91 (depends on 79) The composition according to claim 79, administered to a subject to diminish the effects of a stroke and/or a neurodegenerative disorder, wherein said composition is administered in combination with one or more supplemental agents. ### Claim 92 (depends on 80) The composition according to claim 80, administered to a subject to diminish the effects of a stroke and/or a neurodegenerative disorder, wherein said composition is administered in combination with one or more supplemental agents. ### Claim 93 (depends on 81) The composition according to claim 81, administered to a subject to diminish the effects of a stroke and/or a neurodegenerative disorder, wherein said composition is administered in combination with one or more supplemental agents. ### Claim 94 (depends on 78) The composition according to claim 78, administered to a subject to diminish the effects of a stroke and/or a neurodegenerative disorder, wherein said composition is administered in combination with one or more vitamins, mineral supplements, herbal supplements, fish oils and/or Western medicines. ### Claim 95 (depends on 79) The composition according to claim 79, administered to a subject to diminish the effects of a stroke and/or a neurodegenerative disorder, wherein said composition is administered in combination with one or more vitamins, mineral supplements, herbal supplements, fish oils and/or Western medicines. ### Claim 96 (depends on 80) The composition according to claim 80, administered to a subject to diminish the effects of a stroke and/or a neurodegenerative disorder, wherein said composition is administered in combination with one or more vitamins, mineral supplements, herbal supplements, fish oils and/or Western medicines. ### Claim 97 (depends on 81) The composition according to claim 81, administered to a subject to diminish the effects of a stroke and/or a neurodegenerative disorder, wherein said composition is administered in combination with one or more vitamins, mineral supplements, herbal supplements, fish oils and/or Western medicines.